Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
CTI BIOPHARMA CORP
CUSIP: 12648L601
Class: Common Stock
KBC Group NV's Holding History (CIK: 0001411133)
Note: Option positions (PUT/CALL) are excluded.
Q3 2021
Shares
14,325
Value ($000)
$42
Avg Close
—
Range
—
Q2 2021
Shares
29,947
Value ($000)
$75
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2021
14,325
$42
—
—
Q2 2021
29,947
$75
—
—